TNFAIP3 and hepatocellular carcinoma: miR-138-59 expression was downregulated in these HBV-infected tissues and cells, suggesting that circ-ATP5H could be considered as a potential therapy option for the HCC associated with HBV because ATP5H functions as a miR-138-5p sponge and controls the expression of TNFAIP3 [175].